These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
56 related articles for article (PubMed ID: 3365258)
1. A sequence-dependent monoclonal antibody specific for single-chain urokinase. Charpie JR; Haber E; Matsueda GR Biochem Biophys Res Commun; 1988 Apr; 152(2):910-5. PubMed ID: 3365258 [TBL] [Abstract][Full Text] [Related]
2. Structural and functional characterization of mutants of recombinant single-chain urokinase-type plasminogen activator obtained by site-specific mutagenesis of Lys158, Ile159 and Ile160. Lijnen HR; Nelles L; Van Hoef B; Demarsin E; Collen D Eur J Biochem; 1988 Nov; 177(3):575-82. PubMed ID: 2973984 [TBL] [Abstract][Full Text] [Related]
7. Characterization of hK4 (prostase), a prostate-specific serine protease: activation of the precursor of prostate specific antigen (pro-PSA) and single-chain urokinase-type plasminogen activator and degradation of prostatic acid phosphatase. Takayama TK; McMullen BA; Nelson PS; Matsumura M; Fujikawa K Biochemistry; 2001 Dec; 40(50):15341-8. PubMed ID: 11735417 [TBL] [Abstract][Full Text] [Related]
8. Prostate-specific antigen activates single-chain urokinase-type plasminogen activator. Yoshida E; Ohmura S; Sugiki M; Maruyama M; Mihara H Int J Cancer; 1995 Dec; 63(6):863-5. PubMed ID: 8847146 [TBL] [Abstract][Full Text] [Related]
9. Human single-chain urokinase is activated by the omptins PgtE of Salmonella enterica and Pla of Yersinia pestis despite mutations of active site residues. Järvinen HM; Laakkonen L; Haiko J; Johansson T; Juuti K; Suomalainen M; Buchrieser C; Kalkkinen N; Korhonen TK Mol Microbiol; 2013 Aug; 89(3):507-17. PubMed ID: 23763588 [TBL] [Abstract][Full Text] [Related]
10. A recombinant antibody-targeted plasminogen activator with high affinity for activated platelets increases thrombolytic potency in vitro and in vivo. Wan H; Liu Z; Xia X; Gu J; Wang B; Liu X; Zhu M; Li P; Ruan C Thromb Res; 2000 Feb; 97(3):133-41. PubMed ID: 10680644 [TBL] [Abstract][Full Text] [Related]
11. A region in domain II of the urokinase receptor required for urokinase binding. Bdeir K; Kuo A; Mazar A; Sachais BS; Xiao W; Gawlak S; Harris S; Higazi AA; Cines DB J Biol Chem; 2000 Sep; 275(37):28532-8. PubMed ID: 10864923 [TBL] [Abstract][Full Text] [Related]
12. Regulation of single chain urokinase by small peptides. Higazi A al-R ; Cines D Thromb Res; 1996 Nov; 84(4):243-52. PubMed ID: 8948049 [TBL] [Abstract][Full Text] [Related]
13. A monoclonal antibody against human urokinase: the epitope structure and sequence homology with a human tissue-type plasminogen activator. Takahashi K; Naora H Cell Struct Funct; 1985 Sep; 10(3):195-208. PubMed ID: 2412711 [TBL] [Abstract][Full Text] [Related]
14. The effect of the carboxy-terminal lysine of urokinase on the catalysis of plasminogen activation. Lenich C; Pannell R; Gurewich V Thromb Res; 1991 Oct; 64(1):69-80. PubMed ID: 1776140 [TBL] [Abstract][Full Text] [Related]
15. Characterization of the activation of pro-urokinase by thermolysin. Marcotte PA; Henkin J Biochim Biophys Acta; 1993 Jan; 1161(1):105-12. PubMed ID: 8422417 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of urokinase activity and prevention of urokinase receptor binding by monoclonal antibodies. Zacharias U; Handschack W; Schneider F; Löster K; Kleitke C; Noll F; Will H J Immunol Methods; 1990 Jun; 130(1):81-90. PubMed ID: 2162894 [TBL] [Abstract][Full Text] [Related]
17. Epitope mapping of the anti-urokinase monoclonal antibody 5B4 by isolated domains of urokinase. Corti A; Sarubbi E; Soffientini A; Nolli ML; Zanni A; Galimberti M; Parenti F; Cassani G Thromb Haemost; 1989 Nov; 62(3):934-9. PubMed ID: 2480654 [TBL] [Abstract][Full Text] [Related]
18. Towards effective and safe thrombolysis and thromboprophylaxis: preclinical testing of a novel antibody-targeted recombinant plasminogen activator directed against activated platelets. Wang X; Palasubramaniam J; Gkanatsas Y; Hohmann JD; Westein E; Kanojia R; Alt K; Huang D; Jia F; Ahrens I; Medcalf RL; Peter K; Hagemeyer CE Circ Res; 2014 Mar; 114(7):1083-93. PubMed ID: 24508759 [TBL] [Abstract][Full Text] [Related]
19. Reversible interactions between plasminogen activators and plasminogen activator inhibitor-1. Mimuro J; Kaneko M; Murakami T; Matsuda M; Sakata Y Biochim Biophys Acta; 1992 Dec; 1160(3):325-34. PubMed ID: 1477106 [TBL] [Abstract][Full Text] [Related]